0001760460-20-000002.txt : 20200522 0001760460-20-000002.hdr.sgml : 20200522 20200522072514 ACCESSION NUMBER: 0001760460-20-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200521 FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puissance Life Science Opportunities Fund VI CENTRAL INDEX KEY: 0001760460 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 20903638 BUSINESS ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: FL 25 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2128783702 MAIL ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: FL 25 CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puissance Capital Fund (GP) LLC CENTRAL INDEX KEY: 0001695347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 20903639 BUSINESS ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-878-3700 MAIL ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puissance Capital Management LP CENTRAL INDEX KEY: 0001658437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 20903640 BUSINESS ADDRESS: STREET 1: 950 THIRD AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-878-3700 MAIL ADDRESS: STREET 1: 950 THIRD AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puissance Capital Management (GP) LLC CENTRAL INDEX KEY: 0001695339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 20903641 BUSINESS ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-878-3700 MAIL ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wang Theodore T CENTRAL INDEX KEY: 0001694061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 20903642 MAIL ADDRESS: STREET 1: C/O PUISSANCE CAPITAL MANAGEMENT LP STREET 2: 950 THIRD AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-05-21 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001760460 Puissance Life Science Opportunities Fund VI 950 THIRD AVENUE FL 25 NEW YORK NY 10022 0 0 1 0 0001695347 Puissance Capital Fund (GP) LLC 950 THIRD AVENUE 25TH FLOOR NEW YORK NY 10022 0 0 1 0 0001658437 Puissance Capital Management LP 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 10022 0 0 1 0 0001695339 Puissance Capital Management (GP) LLC 950 THIRD AVENUE 25TH FLOOR NEW YORK NY 10022 0 0 1 0 0001694061 Wang Theodore T C/O PUISSANCE CAPITAL MANAGEMENT LP 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 10022 1 0 1 0 Common Stock 2020-05-21 4 A 0 1153846 13 A 1153846 D These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Puissance Life Science Opportunities Fund VI, By: Puissance Capital Fund (GP) LLC, its managing member, By: Theodore T. Wang, Managing Member 2020-05-22 Puissance Capital Fund (GP) LLC, By: Theodore T. Wang, Managing Member 2020-05-22 Puissance Capital Management LP, By: Puissance Capital Management (GP) LLC, its general partner, By: Theodore T. Wang, Managing Member 2020-05-22 Puissance Capital Management (GP) LLC, By: Theodore Wang, Managing Member 2020-05-22 /s/ Theodore T. Wang 2020-05-22